Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Landing My First MSL Role: From the Inside
Summary
In this episode, Amanda Vaughn joins the discussion to share her transition from academia to the industry and her new role as an MSL at Aglia. Amanda delves into the networking strategies that facilitated her move and the preparations she undertook for her onboarding. She provides insights into tackling interviews and standing out amidst competition in the MSL field. Amanda also offers key advice for aspiring MSLs, drawing from her academic background and previous radio experiences. The episode wraps up with reflections on Amanda's journey and a teaser for future episodes.
Amanda Vaughn, Medical Science Liaison at Aeglea BioTherapeutics shares the story of landing her first MSL job from an inside role within her company.
Amanda shares…
👉 How she landed her first role in the industry
👉 What she was doing to stand out in her role
👉 How she was able to land an interview and what she did to prepare
👉 How she was able to outshine the competition and land the job
👉 Lessons she learned and advice for others
Amanda Vaughn, Medical Science Liaison, MSL career transition, networking strategies in MSL, interview preparation for MSL jobs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO